Skip to content
OpenCapital
Get started

Lipocine LPCN Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

Revenue$3.5MBeat by $877.4K
EPS$0.33Beat by $0.73
Revenue estimate$2.6M
EPS estimate-$0.40

Next report

Aug 4, 2026 (In 5 days)
Revenue estimate$213.0K
EPS estimate-$0.40

Versus estimates

Revenue

Q1 2026$1.2MBeat by $1.0MQ4 2025$1.1MBeat by $1.0MQ3 2025$114.6KMiss by $123.4KQ2 2025$622.8KBeat by $384.8KQ1 2025$93.9KMiss by $258.1K
Q4 2024$3.5MBeat by $877.4K

Diluted EPS

Q1 2026-$0.54Miss by $0.03Q4 2025-$0.34Beat by $0.26Q3 2025-$0.59Miss by $0.03Q2 2025-$0.41In lineQ1 2025-$0.35In line
Q4 2024$0.33Beat by $0.73

Ask the moment Lipocine reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lipocine report Q4 2024 earnings?
Lipocine (LPCN) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Lipocine's Q4 2024 revenue and EPS?
Lipocine reported revenue of $3.5M and eps of $0.33 for Q4 2024.
Did Lipocine beat estimates in Q4 2024?
Revenue beat the consensus estimate of $2.6M by $877.4K. EPS beat the consensus estimate of $-0.40 by $0.73.
Where can I find Lipocine's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-010146) directly on SEC EDGAR. The filing index links above go to sec.gov.